Dr. Reddy's Laboratories Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Nov 19, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, administrative
TL;DR
DRL filed a 6-K, standard foreign issuer report. Nothing new here.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on November 19, 2024, to report information as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, Telangana, India, and its principal executive office is located at 8-2-337, Road No. 3, Banjara Hills.
Why It Matters
This filing provides an update to the SEC regarding Dr. Reddy's Laboratories' status as a foreign private issuer, which is standard procedure for companies listed on US exchanges but headquartered elsewhere.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- Securities Exchange Act of 1934 (legal_document) — Governing regulation
- Hyderabad, Telangana, India (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
When was this Form 6-K filed?
This Form 6-K was filed on November 19, 2024.
Where is Dr. Reddy's Laboratories Limited headquartered?
Dr. Reddy's Laboratories Limited is headquartered in Hyderabad, Telangana, India.
Does Dr. Reddy's Laboratories file an annual report under Form 20-F or 40-F?
The filing indicates that Dr. Reddy's Laboratories files annual reports under cover of Form 20-F.
What is the company's principal executive office address?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-11-19 08:02:26
Filing Documents
- drr0695_6k.htm (6-K) — 14KB
- drr0695_ex99-1.htm (EX-99.1) — 78KB
- drr0695_ex99-1img01.jpg (GRAPHIC) — 3KB
- drr0695_ex99-1img02.jpg (GRAPHIC) — 18KB
- drr0695_ex99-1img03.jpg (GRAPHIC) — 22KB
- 0001575872-24-001184.txt ( ) — 152KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 19, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3